Skip to main content
Premium Trial:

Request an Annual Quote

Belgian Bioinformatics Firm AlgoNomics Wins 1M Grant from Government

NEW YORK, Feb. 22 - Belgian bioinformatics company has been awarded €1 million, or roughly $875,000, by the Flemish Institute for Science and Technology, the company said.

 

AlgoNomics, based in Ghent, said the cash will help develop its structural bioinformatics platform, "including further improvements of its target validation and protein analysis technology," as it applies to HIV research.

 

Founded in 1999, AlgoNomics last June earned €1.8 million euros, or approximately $1.5 million at the time, in a second round of private financing.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.